Precision NeuroMed, Inc.
Clinical-stage biotechnology company developing an integrated platform for loco-regional brain therapy. The platform combines convection-enhanced delivery (CED) hardware, image-based treatment-planning software, and targeted therapeutics to bypass the blood–brain barrier and deliver high local drug concentrations for diseases such as glioblastoma.
Industries
N/A
Products
Integrated loco-regional brain therapy platform
An integrated platform combining CED hardware (microinfusion catheter), image-based treatment-planning software, and support for multiple therapeutic modalities to enable direct delivery of therapeutics to brain tissue.
Clinical-stage targeted protein therapeutic (receptor-targeted)
Development-stage receptor-targeted cytotoxic protein therapy aimed at tumor cell populations in the brain, being advanced with loco-regional delivery to achieve therapeutic concentrations at the disease site.
Integrated loco-regional brain therapy platform
An integrated platform combining CED hardware (microinfusion catheter), image-based treatment-planning software, and support for multiple therapeutic modalities to enable direct delivery of therapeutics to brain tissue.
Clinical-stage targeted protein therapeutic (receptor-targeted)
Development-stage receptor-targeted cytotoxic protein therapy aimed at tumor cell populations in the brain, being advanced with loco-regional delivery to achieve therapeutic concentrations at the disease site.
Services
Image-based treatment planning software
Patient-specific planning software that integrates MRI anatomy with fluid and drug flow models to generate pre- and intra-operative infusion plans.
Image-based treatment planning software
Patient-specific planning software that integrates MRI anatomy with fluid and drug flow models to generate pre- and intra-operative infusion plans.
Expertise Areas
- CNS loco-regional drug delivery
- Neurosurgical device and catheter development
- Treatment-planning software and AI-driven dosing models
- Clinical-stage therapeutic development for brain tumors
Key Technologies
- Convection-enhanced delivery (CED)
- Microinfusion catheter technology
- MRI-based treatment planning (MR-DTI, T2)
- Predictive drug-distribution algorithms